awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38703524-134D7D0C-870E-402E-B63B-916D1434DF14
Q38703524-134D7D0C-870E-402E-B63B-916D1434DF14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38703524-134D7D0C-870E-402E-B63B-916D1434DF14
Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.
P2860
Q38703524-134D7D0C-870E-402E-B63B-916D1434DF14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38703524-134D7D0C-870E-402E-B63B-916D1434DF14
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5f813dd04d5a4eca9ea7af0720e3f2117c74ac62
P2860
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial.